Aclaris Therapeutics to Participate in Upcoming Investor Conferences
November 03 2021 - 7:00AM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage
biopharmaceutical company focused on developing novel drug
candidates for immuno-inflammatory diseases, today announced that
management will participate in the following upcoming investor
conferences:
- Jefferies London Healthcare Conference. Dr.
Neal Walker, the President and CEO of Aclaris, will participate in
a virtual fireside chat which will be available beginning on
Thursday, November 18, 2021 at 3:00 a.m. ET. Management will be
available November 18th throughout the day for virtual one-on-one
meetings.
- Piper Sandler 33rd Annual Virtual Healthcare
Conference. Dr. Walker will participate in a virtual
fireside chat which will be available beginning on Monday, November
22, 2021 at 10:00 a.m. ET. Management will be available December
1st throughout the day for virtual one-on-one meetings.
A live webcast of each fireside chat may be accessed through the
“Events” page of the “Investors” section of Aclaris’ website,
www.aclaristx.com. Each webcast will be archived for at least 30
days on the Aclaris website.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical
company developing a pipeline of novel drug candidates to address
the needs of patients with immuno-inflammatory diseases who lack
satisfactory treatment options. The company has a multi-stage
portfolio of drug candidates powered by a robust R&D engine
exploring protein kinase regulation. For additional information,
please visit www.aclaristx.com.
Aclaris Contact
investors@aclaristx.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Apr 2023 to Apr 2024